SACCARO JAMES
SEC CIK 1593636 · EDGAR
BoughtSold
Most active insiders at GEHC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | CULP H LAWRENCE JR | Dir | $5.00M | — |
| 2 | Lobo Kevin | Dir | $641.8K | — |
| 3 | Arduini Peter J | Pres, CEO, Dir | $249.8K | — |
| 4 | SACCARO JAMES | CFO | $200.6K | — |
| 5 | Jimenez Frank R | GC, Corp. Sec | $105.8K | — |
| 6 | Hochman Rodney F | Dir | $100.4K | — |
| 7 | Yang Watkin Phoebe L. | Dir | $63.0K | — |
| 8 | Stromberg William J | Dir | $61.7K | — |
| 9 | Estrampes Catherine | Chief Commer, Growth Off | — | — |
| 10 | Rackliffe Philip | CEO, AVS | — | — |
Transactions 21
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-01 11:38 | 2026-05-01 | GEHC | GE HealthCare | SACCARO JAMES | CFO | P - Purchase | $60.60 | +3,310 | 87.5K | +4% | +$200.6K | |
| D | 2026-03-04 | 2026-03-02 | GEHC | GE HealthCare | SACCARO JAMES | CFO | A - Grant | $0.00 | +12.5K | 84.2K | +17% | $0 |
| 2026-02-17 | 2026-02-12 | GEHC | GE HealthCare | SACCARO JAMES | CFO | F - Tax | $79.20 | -8,570 | 71.7K | -11% | -$678.7K | |
| 2026-02-17 | 2026-02-12 | GEHC | GE HealthCare | SACCARO JAMES | CFO | A - Grant | $0.00 | +22.6K | 80.3K | +39% | $0 | |
| 2026-02-03 | 2026-02-01 | GEHC | GE HealthCare | SACCARO JAMES | CFO | F - Tax | $78.97 | -948 | 57.6K | -2% | -$74.9K | |
| M | 2025-09-03 | 2025-09-01 | GEHC | GE HealthCare | SACCARO JAMES | CFO | F - Tax | $73.73 | -3,238 | 60.1K | -5% | -$238.7K |
| 2025-06-03 | 2025-06-01 | GEHC | GE HealthCare | SACCARO JAMES | CFO | F - Tax | $70.54 | -9,712 | 61.8K | -14% | -$685.1K | |
| D | 2025-03-05 | 2025-03-03 | GEHC | GE HealthCare | SACCARO JAMES | CFO | A - Grant | $0.00 | +11.3K | 71.5K | +19% | $0 |
| 2025-02-04 | 2025-02-01 | GEHC | GE HealthCare | SACCARO JAMES | CFO | F - Tax | $88.30 | -934 | 60.3K | -2% | -$82.5K | |
| 2024-09-04 | 2024-09-01 | GEHC | GE HealthCare | SACCARO JAMES | CFO | F - Tax | $84.82 | -1,740 | 61.2K | -3% | -$147.6K | |
| 2024-06-04 | 2024-06-01 | GEHC | GE HealthCare | SACCARO JAMES | CFO | F - Tax | $78.00 | -8,998 | 62.9K | -13% | -$701.8K | |
| D | 2024-03-05 | 2024-03-01 | GEHC | GE HealthCare | SACCARO JAMES | CFO | A - Grant | $0.00 | +10.2K | 71.9K | +17% | $0 |
| DM | 2023-06-05 | 2023-06-01 | GEHC | GE HealthCare | SACCARO JAMES | CFO | A - Grant | $0.00 | +61.7K | 61.7K | New | $0 |
| 2023-03-06 | 2023-03-02 | BAX | Baxter International | SACCARO JAMES | EVP, CFO | F - Tax | $39.62 | -1,061 | 177.9K | -0.6% | -$42.0K | |
| D | 2023-03-03 | 2023-03-01 | BAX | Baxter International | SACCARO JAMES | EVP, CFO | A - Grant | $0.00 | +22.2K | 179.0K | +14% | $0 |
| 2023-02-15 | 2023-02-13 | BAX | Baxter International | SACCARO JAMES | EVP, CFO | A - Grant | $0.00 | +3,362 | 157.8K | +2% | $0 | |
| 2023-02-15 | 2023-02-13 | BAX | Baxter International | SACCARO JAMES | EVP, CFO | F - Tax | $40.50 | -1,059 | 156.7K | -0.7% | -$42.9K | |
| D | 2022-03-04 | 2022-03-02 | BAX | Baxter International | SACCARO JAMES | EVP, CFO | A - Grant | $0.00 | +10.7K | 154.3K | +7% | $0 |
| 2022-02-14 | 2022-02-10 | BAX | Baxter International | SACCARO JAMES | EVP, CFO | F - Tax | $87.75 | -4,807 | 143.6K | -3% | -$421.8K | |
| M | 2022-02-14 | 2022-02-10 | BAX | Baxter International | SACCARO JAMES | EVP, CFO | A - Grant | $0.00 | +10.1K | 140.8K | +8% | $0 |
| 2021-09-02 | 2021-09-01 | BAX | Baxter International | SACCARO JAMES | CFO, Executive VP | F - Tax | $77.60 | -34.7K | 138.2K | -20% | -$2.69M |
Purchase Sale Sale after option exercise All abbreviations